32种SARS-CoV-2抗体快速检测试剂的分析性能评估
研究评估了32种SARS-CoV-2抗体快速检测试剂的分析性能,使用262份血清样本(197份大流行前和65份COVID-19康复期),以IgG特异性、敏感性和用户友好性为标准。结果显示IgG特异性在90.9%至100%之间,敏感性在53.8%至98.5%之间;28种检测IgG的试剂中无一种整体性能为「良好」,7种为「可接受」,21种为「不可接受」。
要点
- 低流行率下IgG特异性最重要,需高特异性以减少假阳性。
- 32种快速试剂中无整体性能「良好」者,7种「可接受」。
- 自动化免疫分析IgG敏感性/特异性未超过许多快速试剂。
核心结论
- 低流行率时IgG特异性是关键,应高以减少假阳性。
- 32种快速试剂中无性能「良好」者,7种「可接受」。
- 自动化免疫分析未显示优于快速试剂的IgG性能。
研究设计与样本
- 评估32种SARS-CoV-2抗体快速检测试剂的分析性能。
- 使用262份血清样本:197份大流行前和65份COVID-19康复期。
- 在标准化和优化条件下,根据IgG特异性、敏感性和用户友好性三项标准评估。
- 部分评估了三种自动化免疫分析系统。
主要发现
- IgG特异性范围90.9%(85.9-94.2)至100%(97.7-100.0)。
- IgG敏感性范围53.8%(41.9-65.4)至98.5%(91.0-100.0)。
- 28种检测IgG的快速试剂中,无整体性能「良好」,7种「可接受」,21种「不可接受」。
- 4种仅检测总抗体,未给予整体评估。
- 自动化免疫分析的IgG敏感性/特异性未超过许多快速试剂。
关键数值与推荐
- IgG特异性「良好」:95%CI下限≥97.0%;「可接受」:点估计≥97.0%;否则「不可接受」。
- IgG敏感性「良好」:点估计≥90.0%;「可接受」:≥85.0%;否则「不可接受」。
- 用户友好性「不可接受」:操作复杂或结果难读;否则「良好」。
临床怎么用
- 低流行率环境下应优先选择IgG特异性高的检测以减少假阳性。
- 快速试剂性能差异大,选用时需参考特异性与敏感性数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: To evaluate the analytical performance of 32 rapid tests for detection of antibodies against coronavirus SARS-CoV-2. MATERIALS AND METHODS: We used at total of 262 serum samples (197 pre-pandemic and 65 convalescent COVID-19), and three criteria to evaluate the rapid tests under standardized and optimal conditions: (i) Immunoglobulin G (IgG) specificity "good" if lower limit of the 95% confidence interval was ≥ 97.0%, "acceptable" if point estimate was ≥ 97.0%, otherwise "not acceptable". (ii) IgG sensitivity "good" if point estimate was ≥ 90.0%, "acceptable" if ≥ 85.0%, otherwise "not acceptable". (iii) User-friendliness "not acceptable" if complicated to perform or difficult to read result, otherwise "good". We also included partial evaluations of three automated immunoassay systems. RESULTS: Sensitivity and specificity varied considerably; IgG specificity between 90.9% (85.9-94.2) and 100% (97.7-100.0), and IgG sensitivity between 53.8% (41.9-65.4) and 98.5% (91.0-100.0). Combining our evaluation criteria, none of the 28 rapid tests that detected IgG had an overall performance considered "good", seven tests were considered "acceptable", while 21 tests were considered "not acceptable". Four tests detected only total antibodies and were not given an overall evaluation. IgG sensitivity and/or specificity of the automated immunoassays did not exceed that of many rapid tests. CONCLUSION: When prevalence is low, the most important analytical property is a test's IgG specificity, which must be high to minimize false positive results. Out of 32 rapid tests, none had a performance classified as "good", but seven were classified as "acceptable".
引用
- Tollånes MC, Jenum PA, Kierkegaard H, et al. Evaluation of 32 rapid tests for detection of antibodies against SARS-CoV-2. Clin Chim Acta. 2021. PMID: 33930425. doi:10.1016/j.cca.2021.04.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。